Zobrazeno 1 - 10
of 24
pro vyhledávání: '"L N Shelikhova"'
Autor:
D A SHASHELEVA, A A MASCHAN, L N SHELIKHOVA, U N PETROVA, E E KURNIKOVA, O I ILLARIONOVA, E V BOYAKOVA, G A NOVICHKOVA, M A MASCHAN
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 57-64 (2018)
The main goal is to optimize hematopoietic stem cell transplantation (HSCT) approach among adolescents and young adults with paroxysmal nocturnal hemoglobinuria (PNH) by means of Graft-versus-host disease (GVHD) and post-transplant complications risk
Externí odkaz:
https://doaj.org/article/c5aa744b838d4ea0acb3b3e7f77cb253
Autor:
Y Y DYAKONOVA, O I BYDANOV, A M POPOV, Y V OLSHANSKAYA, E G BOICHENKO, O V ALEYNIKOVA, M A MASCHAN, L N SHELIKHOVA, D V LITVINOV, L A KHACHATRYAN, N I PONOMAREVA, L G FECHINA, G A NOVICHKOVA, E D PASHANOV, A I KARACHUNSKIY
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 37-50 (2018)
Aim. The analysis of experience of nelarabine use in refractory/relapsed T-cell acute lymphoblastic leukemia (T-ALL) depending on the immunophenotype and the line of therapy. Materials and methods. All the patients with relapsed or refractory T-ALL a
Externí odkaz:
https://doaj.org/article/8277c105b38f465fa2bd4074aac1eb65
Publikováno v:
Терапевтический архив, Vol 89, Iss 7, Pp 51-56 (2017)
Aim. To evaluate the safety and efficacy of crizotinib used in pediatric patients with relapsed or refractory ALK-positive anaplastic large-cell lymphoma (ALCL). Subjects and methods. The paper describes the experience with crizotinib used in 8 patie
Externí odkaz:
https://doaj.org/article/bce54223605a4221addab074adf38d3e
Autor:
G A Novichkova, M A Maschan, I P Shipitsyna, Yu V Skvortsova, M I Persiantseva, L L Lebedeva, V O Bobrynina, D D Baidildina, O V Goronkova, G G Solopova, L A Khachatryan, U N Petrova, E V Suntsova, I I Kalinina, V V Sinitsyna, E V Skorobogatova, D N Balashov, Z M Dyshlevaya, L N Shelikhova, E E Kurnikova, P E Trakhtman, A A Maschan
Publikováno v:
Терапевтический архив, Vol 82, Iss 7, Pp 41-47 (2010)
Aim. To analyze the efficiency of transplantation of the bone marrow from a HLA-compatible unrelated donor and continued immunosuppressive therapy (IST) in children with aplastic anemia (AA) unresponsive to 2 courses of IST. Subjects and methods. The
Externí odkaz:
https://doaj.org/article/a539b74b2830479ca8268ed25335826e
Autor:
D. N. Balashov, L. N. Shelikhova, A. A. Demushkina, P. E. Trakhtman, Ye. V. Skorobogatova, D. V. Litvinov, Ye. V. Raykina, A. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 3, Pp 59-64 (2022)
Epstein–Barr virus (EBV) is a member of herpes-viruses family. Now it is well-known, that it can be a cause of wide spectrum lymphoproliferative disoders. The given problem is especially serious after hematopoietic stem cells transplantation (HSCT)
Externí odkaz:
https://doaj.org/article/6030623f2887490c92f3520939b1c2d8
Autor:
Y. V. Skvortsova, D. N. Balashov, Y. Y. Djakonova, Z. M. Dishlevaya, E. E. Kurnikova, N. V. Myakova, V. P. Nazhimov, E. V. Skorobogatova, L. N. Shelikhova, I. P. Shipitsina, P. E. Trakhtman, A. A. Maschan
Publikováno v:
Онкогематология, Vol 0, Iss 1, Pp 29-38 (2022)
Early complications of hematopoietic stem cell transplantation (HSCT) of vascular origin within the first 30-60 days after HSCT, which are resulting from endothelial injury, are an important cause of transplant-associated morbidity and mortality. Aut
Externí odkaz:
https://doaj.org/article/888b9597ef2e4a1fb703facfe3df5490
Autor:
S. K. Arakelyan, S. L. Blagov, S. I. Kovrygin, A. A. Semchenkova, M. S. Fadeeva, D. A. Evseev, T. Yu. Salimova, D. D. Baidildina, L. N. Shelikhova, M. A. Maschan, A. A. Maschan
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 22:104-112
Pure red cell aplasia (PRCA) is a rare complication of AB0-incompatible allogeneic hematopoietic stem cell transplantation, which manifests as a partial or complete absence of erythroid lineage in recipients with normal function of other hematopoieti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94e77c6c761e68bb38a43c5ce7f8091f
https://doi.org/10.24287/1726-1708-2023-22-2-104-112
https://doi.org/10.24287/1726-1708-2023-22-2-104-112
Autor:
T. V. Kudinova, Yu. V. Skvortsova, D. E. Bostanov, О. F. Lukina, E. A. Tikhomirova, D. N. Balashov, L. N. Shelikhova, A. F. Karelin
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 22:60-64
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ce15aa3b83702d03b8bf35aeb550840
https://doi.org/10.24287/1726-1708-2023-22-2-60-64
https://doi.org/10.24287/1726-1708-2023-22-2-60-64
Autor:
D. A. Evstratov, A. D. Shutova, Yu. Yu. Dyakonova, S. A. Radygina, Yu. G. Abugova, L. Kh. Anderzhanova, L. A. Vavilova, D. V. Litvinov, G. A. Novichkova, A. M. Popov, V. V. Fominykh, L. A. Khachatryan, L. N. Shelikhova, N. V. Myakova
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 22:46-52
Today, treatment results for acute lymphoblastic leukemia (ALL) look encouraging, yet 10–15% patients still end up relapsing. The success of relapse treatment is directly dependent on whether or not a tumor clone has been completely eradicated befo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3207d9eaa90510599657df2ed0d9d46c
https://doi.org/10.24287/1726-1708-2023-22-1-46-52
https://doi.org/10.24287/1726-1708-2023-22-1-46-52
Autor:
L. A. Vavilova, Yu. Yu. Dyakonova, O. I. Bydanov, N. V. Myakova, Yu. G. Abugova, L. Kh. Anderzhanova, D. A. Evstratov, E. E. Kurnikova, A. M. Popov, Yu. V. Olshanskaya, M. A. Maschan, L. N. Shelikhova, D. V. Litvinov, A. V. Popa, A. I. Karachunskiy
Publikováno v:
Pediatric Hematology/Oncology and Immunopathology. 22:62-72
Acute lymphoblastic leukemia (ALL) is the most common malignancy in children. Despite remarkable improvements in the treatment of pediatric acute lymphoblastic leukemia over last years, relapse still carries a poor prognosis with considerable morbidi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ed935a04ba533aa4121b7f0900658cc
https://doi.org/10.24287/1726-1708-2023-22-1-62-72
https://doi.org/10.24287/1726-1708-2023-22-1-62-72